Providing technical transfer and validation of a commercial manufacturing process for tablet formulations
Challenge
A US biotech company had a small molecule anti-cancer drug on the market in the US and other products in development. The company needed CMC consulting expertise in order to access European opportunities.
Solution
We provided a European CMC consultant to support the whole process of European transfer and validation. This included:
- overseeing technical transfer of the manufacturing process from the US to selected European contract manufacturers, and validation to meet both European and FDA guidelines
- looking after the technical transfer and validation of packaging activities for the product
- reviewing and approving the batch documentation and reports generated as part of the manufacturing and packaging activities
- providing similar support for the transfer of a second product from the US to a second manufacturing site in Europe
- general CMC consultancy on a wide range of other areas connected with the client’s various development programmes
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
Product Development
Gene therapy preclinical, CMC, and regulatory strategy
Challenge: An early-stage biotechnology startup company reached out to Alacrita for critical support of its two lead AAV-delivered gene therapy programs. As a virtual company, the...
Product Development
Interim chief medical officer for antiviral drug company
Challenge A European company developing novel antiviral drugs urgently needed an experienced pharmaceutical physician to work as an interim CMO, as the predecessor was about to...
Product Development
Preclinical development support for a gene therapy
Challenge: A biotech company developing novel gene therapy approaches for in vivo cell trans-differentiation required an AAV gene therapy expert to serve on a scientific advisory...
Product Development
Primary market research and patient segmentation mapping in myelofibrosis
Challenge: A venture-backed US biotech company was developing a preclinical biologic for haematological indications and wished to quantify the commercial opportunity for the...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.